Contact the Editorial Desk

Editorial correspondence

Peptide Friend welcomes correspondence on the research record: a citation we have quoted inaccurately, a regulatory status that has changed, or a peer-reviewed study about Semax, Selank, or DSIP that should be added to the references page. Corrections that improve the accuracy of the digest are the most useful messages we receive, and they are read carefully.

The most actionable notes specify three things: the page they refer to, the exact passage in question, and the supporting citation — a DOI or PubMed ID wherever possible. That allows us to verify a proposed change against the source without ambiguity.

Editorial mailbox: editors@peptidefriend.com

What this desk cannot do

So that no message goes unanswered for the wrong reason, a few things fall outside what this site can address. Peptide Friend is a literature digest, not a clinic or a vendor, so we cannot:

• Advise on, recommend, or comment on human use of any compound discussed here.
• Suggest a dose, schedule, or route of administration for any individual.
• Diagnose a condition or assess whether a research finding applies to a particular person's situation.
• Sell, source, recommend, or help locate any compound from any supplier.
• Answer requests from athletes subject to anti-doping rules about using these compounds, given the regulatory uncertainties around non-approved substances.

Readers seeking guidance on anxiety, cognitive impairment, or sleep disorders should consult a licensed clinician in their own jurisdiction. Responses to editorial correspondence are not guaranteed and may be delayed; the mailbox is monitored intermittently.